Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Women with acne have lower levels of a specific hormone marker than women without acne.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.